You are here: Industry Insights > SARS-CoV-2

News List

GenScript Receives "COVID Management Initiative of the Year" in Singapore Business Review Management Excellence Award 2021 prnasia
December 15, 2021
GenScript receives the award on COVID Management Initiative of the Year, Biotechnology industry in the Singapore Business Review (SBR) Management Excellence Award 2021.
Pfizer Covid vaccine provides partial protection against Omicron: Study expresspharma
December 10, 2021
The yet-to-be peer-reviewed study, posted on the pre-print repository medRxiv recently, also found that considerable immunity is retained in people who were both vaccinated and previously ...
Evusheld (Formerly AZD7442) Long-Acting Antibody Combination Authorized For Emergency Use In The US For Prevention of COVID-19 AmericanPharmaceuticalReview
December 10, 2021
AstraZeneca's Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody (LAAB) combination, has received emergency use authorization (EUA) in the US for the pre-exposure prophylaxis (prevention) of COVID-19, with first doses expected...
Effectiveness of mRNA COVID-19 Vaccines Lower at ≥120 Days Drugs
December 10, 2021
The vaccine effectiveness (VE) of both the Moderna and Pfizer-BioNTech mRNA vaccines declined at ≥120 days after the second dose, with higher VE and antibody levels for Moderna than Pfizer-BioNTech recipients...
Revealed: How SARS-CoV-2 evades our immune system WorldPharmaNews
December 09, 2021
Scientists at Hokkaido University and Texas A&M University have identified a key mechanism used by the SARS-CoV-2 virus to evade host immune systems.
Sosei Heptares Receives Grant Funding from Wellcome to Advance the Development of Potent, Differentiated Oral Anti-Viral Small Molecules to Treat COVID-19 AmericanPharmaceuticalReview
December 09, 2021
Sosei Group Corporation announced it has received grant funding from Wellcome, through the COVID-19 Therapeutics Accelerator. The funding will be used to advance the pre-clinical development of the Company's novel oral anti-viral small molecules ...
Omicron: Parliamentary panel recommends evaluation of vaccines, more research for booster dose expresspharma
December 07, 2021
The Parliamentary Standing Committee on Health, which presented its report recently, also said that concerns with regard to the new strain developing immunoescape mechanism should be critically addressed
Odds of SARS-CoV-2 Infection Down After Third BNT162b2 Dose Drugs
December 06, 2021
Receipt of a third booster BNT162b2 dose is associated with a reduction in the odds of testing positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), according to a study published online Nov. 30 in JAMA Internal Medicine.
ComCor study: New results on places of infection with SARS-CoV-2 and analysis of the efficacy of messenger RNA vaccines against the Delta variant WorldPharmaNews
December 01, 2021
From May 23 to August 13, 2021, the Institut Pasteur, in partnership with the French National Health Insurance Fund (CNAM), Santé publique France and the Ipsos institute, conducted the fourth part of the ComCor epidemiological study on circumstances...
Emergex T-Cell Priming COVID Vax Candidate Holds Potential Against Omicron prnasia
December 01, 2021
Emergex Vaccines Holding Ltd., a company tackling major global infectious disease threats through the development of 100% synthetic T- Cell priming vaccines, confirmed that its Vaccine candidate for SARS-CoV-2...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page